Molecular Determinants for the Bioactivity of the Flavonoid Quercetin
类黄酮槲皮素生物活性的分子决定因素
基本信息
- 批准号:7666038
- 负责人:
- 金额:$ 11.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-01 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAddressAffectAftercareAntioxidantsApoptosisBacterial DNACarcinogensCell CycleCell DeathCell ProliferationCell SurvivalCellsCessation of lifeClassificationDNA DamageEventFlavonoidsFutureGene ExpressionGene Expression ProfileGenesGoalsHeart DiseasesInflammatoryKnock-outKnowledgeMalignant NeoplasmsMolecularMolecular ProfilingMutateOutcomePathway interactionsPlantsPlayPositioning AttributePreventionPropertyProtein p53ProteinsPublic HealthQuercetinReportingRoleSHPS-1 proteinSignal PathwaySignal TransductionSignaling ProteinTP53 geneTestingTherapeuticTherapeutic AgentsTissue-Specific Gene ExpressionToxic PlantsTumorigenicityangiogenesisantitumor agentcancer cellcell transformationcell typefruits and vegetablesgene functiongenetic regulatory proteinin vivoknock-downneoplastic cellprophylacticresearch studyresponsetool
项目摘要
DESCRIPTION (provided by applicant): Flavonoids constitute a group of polyphenolic compounds primarily known for their anti-oxidant properties. Studies on flavonoids show their promising use for the prevention and treatment of a variety of cancer, inflammatory and heart diseases. Quercetin is a naturally occurring bioactive flavonoid ubiquitously available in fruits, vegetables and other plants. Several studies have shown the bioactivity of Quercetin against a variety of tumor cells and angiogenesis. However, several other studies have also indicated the carcinogenic potential of Quercetin. Moreover, Quercetin has been described as one of the principal molecules of some toxic plants. Therefore, the conditions under which Quercetin is bioactive as an anti-tumor agent or as a carcinogen are not well known. Understanding how Quercetin and other flavonoids function at the molecular level is of paramount importance to public health because it will help us establish the conditions under which specific bioactive flavonoid compounds may or may not be beneficial for therapeutic purposes.
In this study, we propose to determine the mechanisms of Quercetin bioactivity under conditions where specific protein regulators of cell signaling have been ablated. Our specific aims are to examine: (1) what genes are expressed or inhibited by Quercetin; (2) how Quercetin modulates cell survival or cell death through cell signaling regulatory proteins. To address these aims, firstly, we will study the global and differential gene expression profiles of cells, which are intact or null for the p53 protein, by treating them with Quercetin. We will also examine the effect of Quercetin on the expression and function of cell cycle and apoptosis proteins regulated by p53. Secondly, we will analyze the DNA-damage response pathway through examination of the ATM/ATR proteins and downstream events. Thirdly, we will examine the levels and activities of other key cell cycle and apoptosis regulatory proteins after treatment with Quercetin. To examine the role of key proteins identified through the initial treatment experiments, we will use cells knocked out for the proteins or we will knock down the proteins by short interfering RNAs. The results will help us understand if treatment with Quercetin influences cell cycle, apoptosis, and DNA-damage regulatory proteins in cells. In future studies, we will utilize knowledge from these aims to evaluate the effect that Quercetin exerts in tumor cells in vivo.
描述(由申请人提供):类黄酮构成一组主要以其抗氧化特性而闻名的多酚化合物。对类黄酮的研究表明,它们在预防和治疗多种癌症、炎症和心脏病方面具有广阔的前景。槲皮素是一种天然存在的生物活性黄酮类化合物,普遍存在于水果、蔬菜和其他植物中。多项研究表明槲皮素具有抗多种肿瘤细胞和血管生成的生物活性。然而,其他几项研究也表明槲皮素具有致癌潜力。此外,槲皮素被描述为一些有毒植物的主要分子之一。因此,槲皮素作为抗肿瘤剂或致癌剂具有生物活性的条件尚不清楚。了解槲皮素和其他黄酮类化合物如何在分子水平上发挥作用对于公共卫生至关重要,因为它将帮助我们确定特定生物活性黄酮类化合物可能或可能不会有益于治疗目的的条件。
在这项研究中,我们建议确定在细胞信号传导的特定蛋白质调节剂被消除的条件下槲皮素生物活性的机制。我们的具体目标是检查:(1)槲皮素表达或抑制哪些基因; (2)槲皮素如何通过细胞信号调节蛋白调节细胞存活或细胞死亡。为了实现这些目标,首先,我们将通过用槲皮素处理细胞来研究细胞的整体和差异基因表达谱,这些细胞的 p53 蛋白是完整的或无效的。我们还将研究槲皮素对 p53 调节的细胞周期和凋亡蛋白的表达和功能的影响。其次,我们将通过检查 ATM/ATR 蛋白和下游事件来分析 DNA 损伤反应途径。第三,我们将检查槲皮素处理后其他关键细胞周期和凋亡调节蛋白的水平和活性。为了检查通过初始治疗实验确定的关键蛋白质的作用,我们将使用敲除蛋白质的细胞,或者通过短干扰 RNA 敲除蛋白质。这些结果将帮助我们了解槲皮素治疗是否会影响细胞周期、细胞凋亡和细胞中的 DNA 损伤调节蛋白。在未来的研究中,我们将利用这些目标的知识来评估槲皮素在体内肿瘤细胞中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Temesgen Samuel其他文献
Temesgen Samuel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Temesgen Samuel', 18)}}的其他基金
Quercetin as an enhancer of the efficacy of 5-FU in mouse models of colon cancer
槲皮素作为结肠癌小鼠模型中 5-FU 功效的增强剂
- 批准号:
8628386 - 财政年份:2014
- 资助金额:
$ 11.03万 - 项目类别:
Molecular Determinants for the Bioactivity of the Flavonoid Quercetin
类黄酮槲皮素生物活性的分子决定因素
- 批准号:
7901375 - 财政年份:2008
- 资助金额:
$ 11.03万 - 项目类别:
Molecular Determinants for the Bioactivity of the Flavonoid Quercetin
类黄酮槲皮素生物活性的分子决定因素
- 批准号:
7342172 - 财政年份:2008
- 资助金额:
$ 11.03万 - 项目类别:
Project 2: Chemotherapy-induced Immunomodulation in Colon Cancer
项目2:结肠癌化疗诱导的免疫调节
- 批准号:
10328025 - 财政年份:2005
- 资助金额:
$ 11.03万 - 项目类别:
Project 2: Chemotherapy-induced Immunomodulation in Colon Cancer
项目2:结肠癌化疗诱导的免疫调节
- 批准号:
10491179 - 财政年份:2005
- 资助金额:
$ 11.03万 - 项目类别:
Project 2: Chemotherapy-induced Immunomodulation in Colon Cancer
项目2:结肠癌化疗诱导的免疫调节
- 批准号:
10701936 - 财政年份:2005
- 资助金额:
$ 11.03万 - 项目类别:
Molecular Characterization of Aggressive Colon Cancers of African-American.......
非裔美国人侵袭性结肠癌的分子特征......
- 批准号:
8568033 - 财政年份:2005
- 资助金额:
$ 11.03万 - 项目类别:
Molecular Characterization of Aggressive Colon Cancers of African-American.......
非裔美国人侵袭性结肠癌的分子特征......
- 批准号:
8555496 - 财政年份:2005
- 资助金额:
$ 11.03万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 11.03万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 11.03万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 11.03万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 11.03万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 11.03万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 11.03万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 11.03万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 11.03万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 11.03万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 11.03万 - 项目类别:
Research Grant